COVID-19 pandemic drives asthma patients to use telemedicine

COVID-19 has, among other things, pushed patients of all ages into greater use of telemedicine to carry out regular doctor visits.

A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that "show rates" for children with asthma – how often parents brought their kids to an appointment rather than being a "no show" – increased with the use of telemedicine during four months of the pandemic.

It would be normal to expect parents to be hesitant to bring kids into an asthma checkup during a pandemic. We run the LAC+USC Breathmobile program (an urban school-based mobile asthma program) in Los Angeles and have regular asthma patients we work with.

The pandemic in 2020 resulted in closure of most Los Angeles schools and face to face visits were converted to telemedicine visits. We found that not only did kids show up for appointments, but their show rates were also significantly higher than during the same period in 2019."

Kenny Kwong, MD, Study Author and Allergist, American College of Allergy, Asthma, and Immunology

In addition to show rates increasing, Dr. Kwong found that during the telemedicine period over 90% of patients reported well controlled asthma on their asthma control (ACT) test.

This was comparable to pre-Covid visits. Finally, provider and nursing staff from the Breathmobile reported a 32% to 62% increase in time spent with each patient while conducting telemedicine visits compared to in-person visits.

"Kids with asthma need treatment that is consistent and specialized to their individual needs," says allergist Lyne Scott, MD, ACAAI member and co-author of the study. "It's reassuring and encouraging that the quality of care young patients, including those in underserved populations, received via virtual access kept their asthma under control. This study shows it's possible to move towards new models of treatment that increase access and convenience for the patient, and still maintain quality of care."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients